CTXR Stock Analysis: Buy, Sell, or Hold?
CTXR - Citius Pharmaceuticals Inc. Common
$0.70
-0.02 (-2.72%)
▼
5d:
+9.44%
30d:
-18.08%
90d:
-8.47%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CTXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called CTXR this week
0% bullish • 2 bearish
0% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CTXR trading at deep discount. Market pricing in -8.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: CTXR trading at deep discount. Market pricing in -8.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.63
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$1.01
30.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CTXR is currently trading at $0.70, which is considered fair relative to its 30-day fair value range of $0.66 to $0.85. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.2) compared to its historical average (0.3). Remarkably, the market is currently pricing in an annual earnings decline of 8.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CTXR is in a downtrend. Immediate support is located at $0.60, while resistance sits at $0.75.
Market Sentiment: CTXR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+756.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTXR is in a downtrend. Immediate support is located at $0.60, while resistance sits at $0.75.
Market Sentiment: CTXR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+756.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.66 -
$0.85
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 756.7% below Wall St target ($6.00)
Trading Range Analysis
30-Day Trading Range
$0.66 -
$0.85
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$0.75
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.25
Wall Street Target
$6.00
(+756.7%)
Valuation Discount vs History
-8.5% cheaper
PE vs Historical
0.3 vs 0.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.5%
(market-implied from PE analysis)
1-Year Target
$0.64
(-9%)
2-Year Target
$0.59
(-16%)
3-Year Target
$0.54
(-23%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$0.64
(-9%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 68.1%)
$207.82
(+29571%)
Base:
(SPY PE: 0.3, Growth: 68.1%)
$2.36
(+238%)
Bear:
(PE: 0.2, Growth: 68.1%)
$2.01
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.3 to 0.3
Stabilization Target:
$0.84
(+19.5%)
PE Expansion Potential:
+19.5%
Share & Embed Analysis
Last updated: May 18, 2026 6:55 AM ET
Data refreshes hourly during market hours. Next update: 7:55 AM
Data refreshes hourly during market hours. Next update: 7:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTXR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
